Fertility Patch Success

Significant Fertility Advance Cited
By: PharmaLive

From: http://www.pharmalive.com/News/index.cfm?articleid=507526&categoryid=40
Citing a significant advance in drug delivery, Vyteris, Inc. (OTC BB: VYHN) and Ferring Pharmaceuticals today announced results from a completed Phase 1 clinical trial demonstrating that Vyteris’ patented Smart Patch transdermal technology successfully delivered a peptide molecule in humans (multiple pulse) without the use of needles (non invasively) in therapeutic levels aimed at the treatment of female infertility.

Back to the Good News Index | Buy A GenSelect Kit Now

Baby Gender Selection

Buy a kit now!

As Seen On Tv Carolina Urology Practice Ama Logo WebMD Logo